<?xml version="1.0" encoding="UTF-8"?>
<ack id="ceack10">
 <sec>
  <title>Acknowledgments</title>
  <p>The study was co-sponsored by US Department of the Army and GeneOne Life Science, and undertaken at the Walter Reed Army Institute of Research. The GLS-5300 DNA vaccine is being co-developed by GeneOne Life Science and Inovio Pharmaceuticals. This work was supported by a 
   <funding-source id="GS1">cooperative agreement</funding-source> (W81XWH-07-2-0067) between the Henry M Jackson Foundation for the Advancement of Military Medicine, and the US Department of Defense. Data were reviewed by the Walter Reed Army Institute of Research. We thank Sally Sturm and Jooyeon Oh for technical assistance and Eun Hae Oh for administrative assistance (GeneOne Life Science, Blue Bell, PA, USA). The opinions or assertions contained in this report are the private views of the authors, and are not to be construed as official, or as reflecting true views of the US Department of the Army or the US Department of Defense.
  </p>
 </sec>
</ack>
